It has been reported that the tumor expression of PD-L1 is associated with a poor prognosis for several types of cancer, such as pancreatic cancer [12], gastric cancer [13], hepatocellular carcinoma [14], esophageal cancer [15], and renal cell carcinoma [16]. The gene discussed is CD274; the disease is neoplasm.